BREAKING NEWS
This content is not available in your region

Johnson & Johnson posts 23% rise in third-quarter profit

Access to the comments Comments
Johnson & Johnson posts 23% rise in third-quarter profit
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid   -   Copyright  Brendan McDermid(Reuters)
Text size Aa Aa

(Reuters) – Johnson & Johnson <JNJ.N> on Tuesday posted a 22.9% rise in third-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.

Net earnings rose to $4.83 billion, or $1.81 per share, in the quarter, from $3.93 billion, or $1.44 per share, a year earlier.

(Reporting by Saumya Sibi Joseph and Ankur Banerjee in Bengaluru; Editing by Bernard Orr)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.